50 related articles for article (PubMed ID: 8628444)
1. [Ras-oncogene detection in feces of patients with colorectal tumors].
Swinkels DW; de Kok J; van Muijen GN; Willems JL
Ned Tijdschr Geneeskd; 1996 Mar; 140(9):510-1. PubMed ID: 8628444
[No Abstract] [Full Text] [Related]
2. [Blood oncogene detection in patients with colorectal carcinoma].
Raedle J; Brieger A; Zeuzem S
Z Gastroenterol; 1998 Mar; 36(3):257-9. PubMed ID: 9577911
[No Abstract] [Full Text] [Related]
3. Analysis of K-ras in the stools of patients with colorectal tumors.
Pagani R; Porcelli B; Frosi B; Pizzichini M; Civitelli S; Pacchiarotti MC; Arezzini L; Tanzini G; Marinello E
Biochem Soc Trans; 1996 May; 24(2):260S. PubMed ID: 8736918
[No Abstract] [Full Text] [Related]
4. Frequency of Ki-ras mutations and DNA alkylation in colorectal tissue from individuals living in Manchester.
Jackson PE; Hall CN; Badawi AF; O'Connor PJ; Cooper DP; Povey AC
Mol Carcinog; 1996 May; 16(1):12-9. PubMed ID: 8634090
[TBL] [Abstract][Full Text] [Related]
5. Differential activation of the c-Ki-ras-2 proto-oncogene in human colorectal carcinoma.
Halatsch ME; Hirsch-Ernst KI; Weinel RJ; Kahl GF
Anticancer Res; 1998; 18(4A):2323-5. PubMed ID: 9703874
[TBL] [Abstract][Full Text] [Related]
6. Frequent detection of K-ras mutation in stool samples of colorectal carcinoma patients after improved DNA extraction: comparison with tissue samples.
Ito Y; Kobayashi S; Taniguchi T; Kainuma O; Hara T; Ochiai T
Int J Oncol; 2002 Jun; 20(6):1263-8. PubMed ID: 12012008
[TBL] [Abstract][Full Text] [Related]
7. Sampling method as a key factor in identifying K-ras oncogene mutations in preneoplastic colorectal lesions.
Ronai Z; Minamoto T; Butler R; Tobi M; Luo FQ; Zang E; Esumi H; Sugimura T
Cancer Detect Prev; 1995; 19(6):512-7. PubMed ID: 8925520
[TBL] [Abstract][Full Text] [Related]
8. Detection of the mutated K-Ras biomarker in colorectal carcinoma.
Doolittle BR; Emanuel J; Tuttle C; Costa J
Exp Mol Pathol; 2001 Jun; 70(3):289-301. PubMed ID: 11418008
[TBL] [Abstract][Full Text] [Related]
9. Correlation of K-ras codon 12 mutations in human feces and ages of patients with colorectal cancer (CRC).
Chien CC; Chen SH; Liu CC; Lee CL; Yang RN; Yang SH; Huang CJ
Transl Res; 2007 Feb; 149(2):96-102. PubMed ID: 17240321
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic and carcinogenetic appraisal of DNA replication error in sporadic T3N0M0 stage colorectal cancer after curative resection.
Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Chien CT; Wang SM
Hepatogastroenterology; 1999; 46(26):883-90. PubMed ID: 10370632
[TBL] [Abstract][Full Text] [Related]
11. Early Detection of a Colorectal Carcinoma in an Asymptomatic Patient Using a Combined DNA Stool Test.
Amani A; Weber MM; Marko C
Clin Lab; 2019 Sep; 65(9):. PubMed ID: 31532101
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive detection through REMS-PCR technique of K-ras mutations in stool DNA of patients with colorectal cancer.
Mixich F; Ioana M; Voinea F; Săftoiu A; Ciurea T
J Gastrointestin Liver Dis; 2007 Mar; 16(1):5-10. PubMed ID: 17410282
[TBL] [Abstract][Full Text] [Related]
13. Detection of Mutant RAS Subpopulations in Colorectal Cancer Patients.
Banda M
EBioMedicine; 2015 Apr; 2(4):280-1. PubMed ID: 26137569
[No Abstract] [Full Text] [Related]
14. Detection of K-ras point mutation at codon 12 in pancreatic diseases: a study in a Brazilian casuistic.
Kubrusly MS; Cunha JE; Bacchella T; Abdo EE; Jukemura J; Penteado S; Morioka CY; de Souza LJ; Machado MC
JOP; 2002 Sep; 3(5):144-51. PubMed ID: 12221329
[TBL] [Abstract][Full Text] [Related]
15. A French point of view about the cost effectiveness of RASQ61R immunohistochemistry in colorectal cancer.
Uguen A
Pathology; 2017 Dec; 49(7):810-811. PubMed ID: 29061330
[No Abstract] [Full Text] [Related]
16. Is SP174 Immunohistochemistry an Interesting Ancillary Tool to Determine RAS Mutational Status in Colorectal Carcinoma?
Uguen A; Gueguen P; Guibourg B; Duigou S; Pochic M; Conq G; Samaison L; Marcorelles P; De Braekeleer M
Appl Immunohistochem Mol Morphol; 2017 Mar; 25(3):e25-e26. PubMed ID: 27153446
[No Abstract] [Full Text] [Related]
17. RAS pathway activation and an oncogenic RAS mutation in sporadic pilocytic astrocytoma.
Sharma MK; Zehnbauer BA; Watson MA; Gutmann DH
Neurology; 2005 Oct; 65(8):1335-6. PubMed ID: 16247081
[No Abstract] [Full Text] [Related]
18. [Molecular-genetic detection of colorectal carcinoma in the feces].
Offerhaus GJ; Slebos RJ
Ned Tijdschr Geneeskd; 1995 Dec; 139(52):2714-5. PubMed ID: 8569883
[No Abstract] [Full Text] [Related]
19. Improved detection of K-ras codon 12 mutations in fecal exfoliated cells.
Puig P; Urgell E; Capellá G; Villanueva A; Grau M; Sancho FJ; Pujol J; Lluís F; González-Sastre F; Mora J
Lab Invest; 1999 May; 79(5):617-8. PubMed ID: 10334573
[No Abstract] [Full Text] [Related]
20. Suppression of colorectal cancer growth using an adenovirus vector expressing an antisense K-ras RNA.
Nakano M; Aoki K; Matsumoto N; Ohnami S; Hatanaka K; Hibi T; Terada M; Yoshida T
Mol Ther; 2001 Apr; 3(4):491-9. PubMed ID: 11319909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
